Squalamine: An appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Salmi, Chanaz ^c   Loncle, Celine ^c   Vidal, Nicolas ^c   Letourneux, Yves ^c   Fantini, Jacques ^b   Maresca, Marc ^b   Taïeb, Nadira ^b   Pagès, Jean Marie ^c   Brunel, Jean Michel ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Aix Marseille University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; DYE; MEMBRANE LIPID; POLYMYXIN B; SQUALAMINE; CHOLESTANOL; LIPID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; LIPID COMPOSITION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMICAL MODEL; CHEMISTRY; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; METABOLISM; METHODOLOGY; PERMEABILITY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CHOLESTANOLS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; LIPIDS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PERMEABILITY; PHENOTYPE; POLYMYXIN B;

EID: 50649104128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002765     Document Type: Article

References (41)

1. Armstrong D, Neu H, Peterson LR, Tomasz A (1995) The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s. Microb Drug Resist 1: 1-4.
2. Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P, et al. (2001) Surveillance of antimicrobial resistance-xhat, how and whither? Clin Microbiol Infect 7: 316-325.
3. Tomasz A (1994) Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. N Engl J Med 330: 1247-1251.
4. Labischinski H, Barnickel G, Bradaczek H, Naumann D, T. RE, et al. (1985) High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol 162: 9-20.
5. Vaara M (1992) Agents that increase the permeability of the outer membrane. J Microbiol Rev 56: 395-411.
6. Nikaido H (1996) Outer membrane. In: Neidhardt FC, Curtis III R, Ingraham JL, eds. Escherichia coli and Salmonella: cellular and molecular biology. washington: ASM press. pp 29-47.
7. Hancock R (1997) The bacterial outer membrane as a drug barrier. Trends Microbiol 5: 37-42.
8. Murata T, Tseng W, Guina T, Miller SI, Nikaido H (2007) PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium. J Bacteriol 189: 7213-7222.
9. Vaara M (1993) Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative entcric bacteria. Antimicrob Agents and Chemother 37: 354-356.
10. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiology and Molecular Biology Reviews 67: 593-656.
11. Zasloff M (1992) Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 4: 3-7.
12. Zasloff M (1994) Antibacterial molecules from frogs, sharks and man. Phylogenet Perspect Immum Insect Host Def pp 31-41.
13. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature (London, United Kingdom) 415: 389-395.
14. Burns MR, Wood SJ, Miller KA, Nguyen T, Cromer JR, et al. (2005) Lysine-spermine conjugates: hydrophobic polyamine amides as potent lipopolysaccharide sequestrants. Bioorg Med Chem 13: 2523-2536.
15. Hayrinen J, Haseley S, Talaga P, Muhlenhoff M, Finne J, et al. (2002) High affinity binding of long-chain polysialic acid to antibody, and modulation by divalent cations and polyamines. Molecul Immunol 39: 399-411.
16. Sol V, Branland P, Chaleix V, Granet R, Guilloton M, et al. (2004) Amino porphyrins as photoinhibitors of Gram-positive and -negative bacteria. Bioorg Med Chem Lett 14: 4207-4211.
17. Stone R. Deja vu guides the way to new antimicrobial steroid. Science 259: 1125.
18. Ahima Rexford S, Patel Hiralben R, Takahashi N, Qi Y, Hileman Stanley M, et al. (2002) Appetite suppression and weight reduction by a centrally active aminosterol. Diabetes 51: 2099-2104.
19. Boman HG (1991) Antibacterial peptides: key components needed in immunity. Cell 65: 205-207.
20. Brunel JM, Letourneux Y (2003) Recent advances in the synthesis of spermine and spermidine analogs of the shark aminosterol squalamine. Eur J Org Chem. pp 3897-3907.
21. Brunel JM, Salmi C, Loncle C, Vidal N, Letourneux Y (2005) Squalamine: a polyvalent drug or the future? Curr Cancer Drug Targets 5: 267-272.
22. Ding B, Guan Q, Walsh JP, Boswell JS, Winter TW, et al. (2002) Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. J Med Chem 45: 663-669.
23. Moore KS, Wehrli S, Roder H, Rogers M, Forrest JN jr, et al. (1993) Squalamine: An aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 90: 1354-1358.
24. Rao MN, Shinnar AE, Noecker LA, Chao TL, Feibush B, et al. (2000) Aminosterols from the dogfish shark Squalus acanthias. J Nat Prod 63: 631-635.
25. Zavascki AP, Goldani LZ, Li J, Nation RL (2007) Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob and Chemother 60: 1206-1215.
26. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, et al. (2006) Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Diseases 6: 589-601.
27. Thiolas A, Bollet C, La Scola B, Raoult D, Pages J-M (2005) Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents and Chemother 49: 1354-1358.
28. Pradel E, Pages J-M (2002) The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents and Chemother 46: 2640-2643.
29. Kwon DH, Lu CD (2006) Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa. Antimicrob Agents and Chemother 50: 1623-1627.
30. Kwon DH, Lu CD (2007) Polyamine effects on antibiotic susceptibility in bacteria. Antimicrob Agents and Chemother 51: 2070-2077.
31. Yasuda K, Ohmizo C, Katsu T (2004) Mode of action of novel polyamines increasing the permeability of bacterial outer membrane. Int J Antimicrob Agents 24: 67-71.
32. Kügler R, Bouloussa O, Rondelez F (2005) Evidence of a charge-density threshold for optimum efficiency of biocidal cationic surfaces. Microbiol 151: 1341-1348.
33. Peschel A (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol 10: 179-186.
34. Selinsky BS, Zhou Z, Fojtik KG, Jones SR, Dollahon NR, et al. (1998) The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles. Biochimica et Biophysica Acta 1370: 218-234.
35. Garmy N, Taieb N, Yahi N, Fantini J, Journal of Lipid Research (2005), 36-45. (2005) Interaction of cholesterol with sphingosine: Physicochemical characterization and impact on intestinal absorption. J Lipid Res 46: 36-45.
36. Dean CR, Narayan S, Daigle DM, Dzink-Fox JL, Puyang X, et al. (2005) Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415. Antimicrob Agents and Chemother 49: 3129-3135.
37. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Soenksen CP, et al. (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (London, United Kingdom) 437: 975-980.
38. Wang J, Soisson SM, Young K, Shoop W, Kodali S, et al. (2006) Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature (London, United Kingdom) 441: 358-361.
39. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, et al. (2007) Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2: No pp. given.
40. Niven GW, Mulholland F (1998) Cell membrane integrity and lysis in Lactococcus lactis: the detection of a population of permeable cells in post-logarithmic phase cultures. J Appl Microbiol 84: 90-96.
41. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F (1993) Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci USA 90: 2700-2704.